miRNA-711 Binds and Activates TRPA1 Extracellularly to Evoke Acute and Chronic Pruritus

Increasing evidence suggests that extracellular miRNAs may serve as biomarkers of diseases, but the physiological relevance of extracellular miRNA is unclear. We find that intradermal cheek injection of miR-711 induces TRPA1-depedent itch (scratching) without pain (wiping) in naive mice. Extracellular perfusion of miR-711 induces TRPA1 currents in both Trpa1-expressing heterologous cells and native sensory neurons through the core sequence GGGACCC. Computer simulations reveal that the core sequence binds several residues at the extracellular S5-S6 loop of TRPA1, which are critical for TRPA1 activation by miR-711 but not allyl isothiocyanate. Intradermal inoculation of human Myla cells induces lymphoma and chronic itch in immune-deficient mice, associated with increased serum levels of miR-711, secreted from cancer cells. Lymphoma-induced chronic itch is suppressed by miR-711 inhibitor and a blocking peptide that disrupts the miR-711/TRPA1 interaction. Our findings demonstrated an unconventional physiological role of extracellular naked miRNAs as itch mediators and ion channel modulators. •Intradermal miR-711 evokes itch but not pain via core sequence and TRPA1•miR-711 is sufficient to activate pruriceptive neurons via TRPA1 in mouse DRG•The core sequence GGGACCC binds and activates TRPA1 at the extracellular S5-S6 loop•Skin lymphoma-secreted miR-711 drives itch in a mouse model of chronic itch How extracellular miRNA signals is unclear. Han et al. describe that miRNA-711, secreted from inoculated lymphoma cells on the back skin, binds TRPA1 ion channels extracellularly on pruriceptive neurons to drive acute and chronic itch via specific core sequence.